Clinical Trials · NCT04172987
A Study of the Effect of Tirzepatide on How the Body Handles Birth Control Pills in Healthy Female Participants
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Eli Lilly and Company
- Enrollment
- 40
- Start date
- Feb 2020
- Locations
- 1 site, United States
- Primary endpoint
- Period 1 and Period 2, Pharmacokinetics (PK): Area Under the Concentration Versus Time Curve (AUC) Within 1 Dosing Interval (AUC[0-tau]) of Ethinylestradiol (EE)